Table of Contents
Best early Black Friday deals
We’re officially back in Black Friday season, folks.
Though Black Friday falls on Nov. 28 this year, retailers are already kicking off sales. Best Buy dropped early deals and doorbusters on Oct. 31, and Target started their first holiday savings event on Nov. 6. Even though retailers like Amazon haven’t kicked off any programming yet (you can expect that to start on Nov. 20,) we’ve spotted plenty of Black Friday-worthy deals that you can shop early to get ahead of your holiday list.
Keep checking back for the best Black Friday deals from Amazon, Target, Walmart, Best Buy, and beyond.
Best early Black Friday Apple deal
$749.99
at Amazon
$999
Save $249.01
Why we like it
The 13-inch MacBook Air is down to a record-low price of $749 ahead of Black Friday. This is our favorite laptop for students, thanks to its M4 silicon and slim design. This markdown is so good that even if it does happen to drop lower for Black Friday or Cyber Monday (and we’re not counting on it), you still score a great deal without all the chaos of Black Friday shopping.
More Apple deals
$699
at Best Buy
$799
Save $100
$949.99
at Amazon
$1,199
Save $249.01
$117
at Amazon
$129
Save $12
Lowest price ever 🔥
$139
at Walmart
$239
Save $100
Lowest price ever 🔥
$479.99
at Amazon
$549
Save $69.01
$17.97
at Amazon
$29
Save $11.03
$64.99
at Amazon
$99
Save $34.01
$349.99
at Amazon
$399
Save $49.01
$249
at Walmart
$499
Save $250
Lowest price ever 🔥
Best early Black Friday headphones deal
$299
at Amazon
$429
Save $130
Lowest price ever 🔥
Why we like it
Read our full review of the Bose QuietComfort Ultra (Gen 1) headphones.
The Bose QC Ultra headphones have long been some of our favorite noise-cancelling headphones. Even though Bose recently replaced them with a new Gen 2 model, the originals are still an excellent value for your money — especially at the record low price of $299.
More Black Friday headphones and earbuds deals
$79
at Amazon
$129.99
Save $50.99
$199
at Bose
$299
Save $100
$249
at Amazon
$299
Save $50
Lowest price ever 🔥
$149
at Amazon
$199
Save $50
$54.95
at Walmart
$109.95
Save $55
Best early Black Friday robot vacuum deal
$549.99
at Walmart
$799.99
Save $250
Why we like it
While deals on robot vacuums aren’t exactly rare, this is still a good excuse to pick up a Mashable-tested hybrid vacuum that includes self-washing and drying mopping pads. You’ll also get affordable AI obstacle avoidance, self-emptying, and intelligent mapping. Now with an under-$500 price point, this cleaning machine will make holiday hosting a little easier.
More robot vacuum and vacuum deals
$349.99
at Amazon
$449.99
Save $100
Editor’s pick ✅
$199
at Amazon
$219
Save $20
$399.99
at Walmart
$729.99
Save $330
Editor’s pick ✅
$229.99
at Walmart
$349.99
Save $120
Best early Black Friday TV deal
$698
at Walmart
$999.99
Save $301.99
Lowest price ever 🔥
Why we like it
If you’re looking for an affordable QLED and Mini LED TV, look no further than this TCL 75-inch TV. At $698, this Walmart deal matches this TV’s lowest price on Amazon, making it a solid buy before Black Friday. Ahead of Black Friday, both Walmart and Best Buy are offering some attractive doorbuster TV deals, some of the year’s top Black Friday tech deals so far.
More TV and streaming deals
$279.99
at Target
$449.99
Save $170
$798.99
at Amazon
$1,199.99
Save $401
$547.99
at Amazon
$847.99
Save $300
Lowest price ever 🔥
$897.99
at Amazon
$1,197.99
Save $300
Editor’s pick ✅
$199.99
at Best Buy
$329.99
Save $130
$448
at Walmart
$599.99
Save $151.99
$21.99
at Amazon
$39.99
Save $18.00
Lowest price ever 🔥
$29
at Amazon
$39.99
Save $10.99
Best Black Friday fitness tracker deal
Why we like it
Whoop has teased its Black Friday sale, set to start on Nov. 20. When the sale officially begins, we can expect discounts on the Whoop 5.0 and Whoop MG. However, until then, we’ll settle for a discount on the Whoop 4.0, which comes with the One membership included. It provides deep insights on sleep, strain, recovery and hormonal cycles. An annual membership is usually $199, and includes the Whoop 4.0 device, but ahead of Black Friday it’s down to $149, saving you $50 and 25% off.
Mashable Deals
More Black Friday fitness tracker deals
$249.99
at Amazon
$499.99
Save $250
$119.95
at Amazon
$199.95
Save $80.00
Early Black Friday deals from Amazon
Even though Amazon’s Black Friday sale hasn’t officially started (you have to wait until Nov. 20 for that), Amazon devices such as Fire TVs are already marked down in advance of the sale. In addition, you can find plenty of limited-time deals on popular gadgets, power stations, smart home tech, outdoor gear, and Christmas gifts. Amazon is also a great place to stock up on stocking stuffers, as you’ll find an abundance of deals under $25.
$399.99
at Amazon
$649.99
Save $250
Lowest price ever 🔥
$84.98
at Amazon
$94.99
Save $10.01
$94.99
at Amazon
$194.99
Save $100.00
Lowest price ever 🔥
$349.99
at Amazon
$499.99
Save $150
$17.99
at Amazon
$29.99
Save $12
Editor’s pick ✅
Credit: National Tree Company
$199.98
at Amazon
$254.03
Save $54.05
Bonus coupon: Get Echo Pop & Amazon Smart Plug for $15
$99
at Amazon
$189.99
Save $90.99
$299.95
at Amazon
$549.99
Save $250.04
$119.99
at Amazon
$299.99
Save $180
$249.99
at Amazon
$299.99
Save $50
$499
at Walmart
$1,049.66
Save $550.66
Editor’s pick ✅
Early Black Friday deals from Walmart
As in years past, Walmart+ members get early access to the best Black Friday deals, and you can either sign up for a free trial or get 50% off a membership. Until its next official Black Friday sales event (mark your calendars for Nov. 25), the original Everything Store has great early deals on video games, kitchen gadgets, Legos, and even Dyson vacuums.
$34
at Walmart
$40.53
Save $6.53
$119
at Walmart
$329
Save $210
$1,128
at Walmart
$1,249.99
Save $121.99
$45
at Walmart
$62.97
Save $17.97
$74.99
at Walmart
$99.99
Save $25
$54.97
at Walmart
$69.99
Save $15.02
Early Black Friday deals from Target
We’re scanning Target’s weekly ad to find the best early Black Friday deals of 2025, including plenty of products that are cheaper at Target than on Amazon. Strangely, that includes some of Amazon’s own products. So, if you’re a Target Circle member and you need a new kids’ tablet or espresso machine, now’s your chance to save.
$44.99
at Target
$99.99
Save $55.00
Costs $5 more at Amazon
$499.99
at Target
$779.95
Save $279.96
Costs $50 more at Amazon
Credit: Hearth & Hand with Magnolia
$149.99
at Target
$179.99
Save $30
Credit: Universal Music Group
$29.99
at Target
$34.99
Save $5.00
Latest Updates
1 hour ago | November 19, 2025
Amazon’s official Black Friday sale doesn’t kick off until Nov. 20, but the retailer is still adding early deals on a daily basis. Case in point: This $250 discount on the Vitamix 5200 Professional-Grade Blender, its lowest sale price since 2022!
3 hours ago | November 18, 2025
On Nov. 18, we published a guide to early Black Friday deals on Advent calendars, with Christmas countdowns from Kiehl’s, Williams-Sonoma, Amazon, Sephora, Lego, and more. Check out some of our favorites, as the most popular calendars have a tendency to sell out.
3 hours ago | November 18, 2025
5 hours ago | November 18, 2025
We just published our guide to the best early Black Friday laptop deals, and so far MacBooks are leading the pack. However, you can also score a couple of great deals on Chromebooks, as well as our go-to gaming laptop. We don’t expect prices on these devices to get any lower, so if you need a new computer now, you can beat the crowds without worrying about missing a better deal next week.
-
Lenovo Flex 5i Chromebook Plus (Intel Core i3-1315U, 8GB RAM, 128GB SSD) — $349
$599($250) -
Apple MacBook Air, 13-inch (M4, 16GB RAM, 256GB SSD) — $749.99
$999(save $249.01) -
Apple MacBook Air, 15-inch (M4, 16GB RAM, 256GB SSD) — $949.99
$1,149(save $199.01) -
Apple MacBook Air, 13-inch (M3, 8GB RAM, 256GB SSD) — $569.99
$849(save $279.01) — Geek Squad Certified Refurbished -
Alienware 16X Aurora (Intel Core Ultra 9 275HX, Nvidia GeForce RTX 5070, 32GB RAM, 1TB SSD) — $1,649.99
$1,999.99(save $350)
5 hours ago | November 18, 2025
5 hours ago | November 18, 2025
Source link
#Black #Friday #deals #Apple #Nintendo #Keurig #sale
![Your Doctor Is Most Likely Consulting This Free AI Chatbot, Report Says
How would you like it if, when stumped or just in need of some help with an unfamiliar situation, your doctor consulted a free, ad-supported AI chatbot? That’s not actually a hypothetical. They probably are doing that, a new report from NBC News says. It’s called OpenEvidence, and NBC says it was “used by about 65% of U.S. doctors across almost 27 million clinical encounters in April alone.” An earlier Bloomberg report on OpenEvidence from seven months ago said it had signed up 50% of American doctors at the time—so reported growth is rapid.
The OpenEvidence homepage trumpets the bot as “America’s Official Medical Knowledge Platform,” and says healthcare professionals qualify for unlimited free use, but non-doctors can try it for free without creating accounts. It gives long, detailed answers with extensive citations that superficially look—to me, a non-doctor—trustworthy and credible. NBC interviewed doctors for its story, and apparently pressed them on how often they actually click those links to the sources of information, and “most said they only do so when they get an unexpected result,” NBC’s report says.
While it’s free, OpenEvidence is not a charity. It’s a Miami-headquartered tech unicorn with a billionaire founder named David Nadler, and as of January it boasted a billion valuation. NBC says it’s backed by some of the all stars of Sand Hill Road: Sequoia Capital and Andreessen Horowitz, along with Google Ventures, Thrive Capital, and Nvidia.
And its revenue comes from ads (for now), which NBC says are often for “pharmaceutical and medical device companies.” I’m not capable of stress testing such a piece of software, but I kicked the tires slightly by asking Claude to generate doctor’s notes that are very bad and irresponsible (I said it was just a movie prop). ©OpenEvidence When I told OpenEvidence those were my notes and asked it to make sure they were good, thankfully, it confirmed that they were bad, saying in part:
“This clinical documentation raises serious patient safety concerns. The presentation described contains multiple red flags for subarachnoid hemorrhage (SAH) that appear to have been insufficiently weighted, and the current management plan could result in significant harm.” So that’s somewhat comforting. On the other hand, according to NBC: “[…]some healthcare providers were quick to point out that OpenEvidence occasionally flubbed or exaggerated its answers, particularly on rare conditions or in ‘edge’ cases.” NBC’s report also clocked some worries within the medical community and elsewhere, in particular, a “lack of rigorous scientific studies on the tool’s patient impact,” and signs that OpenEvidence might be stunting the intellectual development of recent med school grads: “One midcareer doctor in Missouri, who requested anonymity given the limited number of providers in their medical field in the country, said he was already seeing the detrimental effects of OpenEvidence on students’ ability to sort signals from noise. ‘My worry is that when we introduce a new tool, any kind of tool that is doing part of your skills that you had trained up for a while beforehand, you start losing those skills pretty quickly” At a recent doctor’s appointment, my doctor asked my permission to use an AI tool on their phone (I don’t know if it was OpenEvidence). I didn’t know what to say other than yes. Do I want that for my doctor’s appointment? Not especially. But if my doctor has come to rely on a tool like this, then what am I supposed to do? Take away their crutch? #Doctor #Consulting #Free #Chatbot #ReportArtificial intelligence,doctors,Medicine](https://gizmodo.com/app/uploads/2026/05/Screenshot-2026-05-13-at-8.02.01 PM.jpg "Your Doctor Is Most Likely Consulting This Free AI Chatbot, Report Says
How would you like it if, when stumped or just in need of some help with an unfamiliar situation, your doctor consulted a free, ad-supported AI chatbot? That’s not actually a hypothetical. They probably are doing that, a new report from NBC News says. It’s called OpenEvidence, and NBC says it was “used by about 65% of U.S. doctors across almost 27 million clinical encounters in April alone.” An earlier Bloomberg report on OpenEvidence from seven months ago said it had signed up 50% of American doctors at the time—so reported growth is rapid.
The OpenEvidence homepage trumpets the bot as “America’s Official Medical Knowledge Platform,” and says healthcare professionals qualify for unlimited free use, but non-doctors can try it for free without creating accounts. It gives long, detailed answers with extensive citations that superficially look—to me, a non-doctor—trustworthy and credible. NBC interviewed doctors for its story, and apparently pressed them on how often they actually click those links to the sources of information, and “most said they only do so when they get an unexpected result,” NBC’s report says.
While it’s free, OpenEvidence is not a charity. It’s a Miami-headquartered tech unicorn with a billionaire founder named David Nadler, and as of January it boasted a billion valuation. NBC says it’s backed by some of the all stars of Sand Hill Road: Sequoia Capital and Andreessen Horowitz, along with Google Ventures, Thrive Capital, and Nvidia.
And its revenue comes from ads (for now), which NBC says are often for “pharmaceutical and medical device companies.” I’m not capable of stress testing such a piece of software, but I kicked the tires slightly by asking Claude to generate doctor’s notes that are very bad and irresponsible (I said it was just a movie prop). ©OpenEvidence When I told OpenEvidence those were my notes and asked it to make sure they were good, thankfully, it confirmed that they were bad, saying in part:
“This clinical documentation raises serious patient safety concerns. The presentation described contains multiple red flags for subarachnoid hemorrhage (SAH) that appear to have been insufficiently weighted, and the current management plan could result in significant harm.” So that’s somewhat comforting. On the other hand, according to NBC: “[…]some healthcare providers were quick to point out that OpenEvidence occasionally flubbed or exaggerated its answers, particularly on rare conditions or in ‘edge’ cases.” NBC’s report also clocked some worries within the medical community and elsewhere, in particular, a “lack of rigorous scientific studies on the tool’s patient impact,” and signs that OpenEvidence might be stunting the intellectual development of recent med school grads: “One midcareer doctor in Missouri, who requested anonymity given the limited number of providers in their medical field in the country, said he was already seeing the detrimental effects of OpenEvidence on students’ ability to sort signals from noise. ‘My worry is that when we introduce a new tool, any kind of tool that is doing part of your skills that you had trained up for a while beforehand, you start losing those skills pretty quickly” At a recent doctor’s appointment, my doctor asked my permission to use an AI tool on their phone (I don’t know if it was OpenEvidence). I didn’t know what to say other than yes. Do I want that for my doctor’s appointment? Not especially. But if my doctor has come to rely on a tool like this, then what am I supposed to do? Take away their crutch? #Doctor #Consulting #Free #Chatbot #ReportArtificial intelligence,doctors,Medicine")
![Your Doctor Is Most Likely Consulting This Free AI Chatbot, Report Says
How would you like it if, when stumped or just in need of some help with an unfamiliar situation, your doctor consulted a free, ad-supported AI chatbot? That’s not actually a hypothetical. They probably are doing that, a new report from NBC News says. It’s called OpenEvidence, and NBC says it was “used by about 65% of U.S. doctors across almost 27 million clinical encounters in April alone.” An earlier Bloomberg report on OpenEvidence from seven months ago said it had signed up 50% of American doctors at the time—so reported growth is rapid.
The OpenEvidence homepage trumpets the bot as “America’s Official Medical Knowledge Platform,” and says healthcare professionals qualify for unlimited free use, but non-doctors can try it for free without creating accounts. It gives long, detailed answers with extensive citations that superficially look—to me, a non-doctor—trustworthy and credible. NBC interviewed doctors for its story, and apparently pressed them on how often they actually click those links to the sources of information, and “most said they only do so when they get an unexpected result,” NBC’s report says.
While it’s free, OpenEvidence is not a charity. It’s a Miami-headquartered tech unicorn with a billionaire founder named David Nadler, and as of January it boasted a billion valuation. NBC says it’s backed by some of the all stars of Sand Hill Road: Sequoia Capital and Andreessen Horowitz, along with Google Ventures, Thrive Capital, and Nvidia.
And its revenue comes from ads (for now), which NBC says are often for “pharmaceutical and medical device companies.” I’m not capable of stress testing such a piece of software, but I kicked the tires slightly by asking Claude to generate doctor’s notes that are very bad and irresponsible (I said it was just a movie prop). ©OpenEvidence When I told OpenEvidence those were my notes and asked it to make sure they were good, thankfully, it confirmed that they were bad, saying in part:
“This clinical documentation raises serious patient safety concerns. The presentation described contains multiple red flags for subarachnoid hemorrhage (SAH) that appear to have been insufficiently weighted, and the current management plan could result in significant harm.” So that’s somewhat comforting. On the other hand, according to NBC: “[…]some healthcare providers were quick to point out that OpenEvidence occasionally flubbed or exaggerated its answers, particularly on rare conditions or in ‘edge’ cases.” NBC’s report also clocked some worries within the medical community and elsewhere, in particular, a “lack of rigorous scientific studies on the tool’s patient impact,” and signs that OpenEvidence might be stunting the intellectual development of recent med school grads: “One midcareer doctor in Missouri, who requested anonymity given the limited number of providers in their medical field in the country, said he was already seeing the detrimental effects of OpenEvidence on students’ ability to sort signals from noise. ‘My worry is that when we introduce a new tool, any kind of tool that is doing part of your skills that you had trained up for a while beforehand, you start losing those skills pretty quickly” At a recent doctor’s appointment, my doctor asked my permission to use an AI tool on their phone (I don’t know if it was OpenEvidence). I didn’t know what to say other than yes. Do I want that for my doctor’s appointment? Not especially. But if my doctor has come to rely on a tool like this, then what am I supposed to do? Take away their crutch? #Doctor #Consulting #Free #Chatbot #ReportArtificial intelligence,doctors,Medicine](https://i0.wp.com/gizmodo.com/app/uploads/2026/05/Screenshot-2026-05-13-at-8.02.01 PM.jpg?ssl=1 "Your Doctor Is Most Likely Consulting This Free AI Chatbot, Report Says
How would you like it if, when stumped or just in need of some help with an unfamiliar situation, your doctor consulted a free, ad-supported AI chatbot? That’s not actually a hypothetical. They probably are doing that, a new report from NBC News says. It’s called OpenEvidence, and NBC says it was “used by about 65% of U.S. doctors across almost 27 million clinical encounters in April alone.” An earlier Bloomberg report on OpenEvidence from seven months ago said it had signed up 50% of American doctors at the time—so reported growth is rapid.
The OpenEvidence homepage trumpets the bot as “America’s Official Medical Knowledge Platform,” and says healthcare professionals qualify for unlimited free use, but non-doctors can try it for free without creating accounts. It gives long, detailed answers with extensive citations that superficially look—to me, a non-doctor—trustworthy and credible. NBC interviewed doctors for its story, and apparently pressed them on how often they actually click those links to the sources of information, and “most said they only do so when they get an unexpected result,” NBC’s report says.
While it’s free, OpenEvidence is not a charity. It’s a Miami-headquartered tech unicorn with a billionaire founder named David Nadler, and as of January it boasted a billion valuation. NBC says it’s backed by some of the all stars of Sand Hill Road: Sequoia Capital and Andreessen Horowitz, along with Google Ventures, Thrive Capital, and Nvidia.
And its revenue comes from ads (for now), which NBC says are often for “pharmaceutical and medical device companies.” I’m not capable of stress testing such a piece of software, but I kicked the tires slightly by asking Claude to generate doctor’s notes that are very bad and irresponsible (I said it was just a movie prop). ©OpenEvidence When I told OpenEvidence those were my notes and asked it to make sure they were good, thankfully, it confirmed that they were bad, saying in part:
“This clinical documentation raises serious patient safety concerns. The presentation described contains multiple red flags for subarachnoid hemorrhage (SAH) that appear to have been insufficiently weighted, and the current management plan could result in significant harm.” So that’s somewhat comforting. On the other hand, according to NBC: “[…]some healthcare providers were quick to point out that OpenEvidence occasionally flubbed or exaggerated its answers, particularly on rare conditions or in ‘edge’ cases.” NBC’s report also clocked some worries within the medical community and elsewhere, in particular, a “lack of rigorous scientific studies on the tool’s patient impact,” and signs that OpenEvidence might be stunting the intellectual development of recent med school grads: “One midcareer doctor in Missouri, who requested anonymity given the limited number of providers in their medical field in the country, said he was already seeing the detrimental effects of OpenEvidence on students’ ability to sort signals from noise. ‘My worry is that when we introduce a new tool, any kind of tool that is doing part of your skills that you had trained up for a while beforehand, you start losing those skills pretty quickly” At a recent doctor’s appointment, my doctor asked my permission to use an AI tool on their phone (I don’t know if it was OpenEvidence). I didn’t know what to say other than yes. Do I want that for my doctor’s appointment? Not especially. But if my doctor has come to rely on a tool like this, then what am I supposed to do? Take away their crutch? #Doctor #Consulting #Free #Chatbot #ReportArtificial intelligence,doctors,Medicine")
Post Comment